Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Novo Nordisk ( NVO 1.34%) and Regeneron Pharmaceuticals ( REGN -0.27%), two leading drugmakers, have underperformed for most ...

Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

Manish Malhotra showcased some of his most iconic designs, like Priyanka Chopra’s “Desi Girl” sari and Kajol’s green lehenga ...

Chanelle Hayes has revealed her horrific ordeal with 'dumping syndrome' after having gastric band surgery to control her ...

Miracle’ drugs used for weight-loss like Semaglutide and Tirzepatide—better known by their brand names Ozempic and ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.

In this Saturday edition of Business Insider Today, we're talking about the peptide injection craze, plus morning routines ...

People are injecting peptides to build muscle, trim fat, and reduce inflammation. Does it work?

New research reveals GLP-1 drugs like Ozempic may reduce stroke risk and improve recovery. At the 22nd Annual Meeting of the ...